Biblio

[ Author(Desc)] Title Type Year
Filters: First Letter Of Title is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Basheer FT, Vassiliou GS. Genome-scale drop-out screens to identify cancer cell vulnerabilities in AML. Curr Opin Genet Dev. 2019;54:83-87.
Bashiri Z, Moghaddaszadeh A, Falak R, Khadivi F, Afzali A, Abasi M, Sharifi AMohammad, Asgari H, Ghanbari F, Koruji M. Generation of Haploid Spermatids on Silk Fibroin-Alginate-Laminin-Based Porous 3D Scaffolds. Macromol Biosci. 2023:e2200574.
Baskfield A, Li R, Beers J, Zou J, Liu C, Zheng W. Generation of an induced pluripotent stem cell line (TRNDi004-I) from a Niemann-Pick disease type B patient carrying a heterozygous mutation of p.L43_A44delLA in the SMPD1 gene. Stem Cell Res. 2019;37:101436.
Batissoco ACarla, Cruz DBernardino, Alegria TGeronimo P, Kobayashi G, Oiticica J, Netto LEduardo So, Passos-Bueno MRita, Haddad LAmaral, Netto RCélia Min. GJB2 c.35del variant up-regulates GJA1 gene expression and affects differentiation of human stem cells. Genet Mol Biol. 2024;47(2):e20230170.
Batool L, Raab C, Beez CMadlen, Hariharan K, Kurtz A, Gollasch M, Rossbach B. Generation of human induced pluripotent stem cell line (BCRTi006-A) from a patient with focal segmental glomerulosclerosis disease. Stem Cell Res. 2023;69:103070.
Batool L, Storozhuk O, Raab C, Beez CMadlen, Selig M, Harder A, Kurtz A. Generation of two human induced pluripotent stem cell lines from a patient with Neurofibromatosis type 1 (NF1) and pathogenic NF1 gene variant c.1466 A>G BCRTi011-A as well as a first-degree healthy relative (BCRTi010-A). Stem Cell Res. 2023;71:103184.
Baubec T, Colombo DF, Wirbelauer C, Schmidt J, Burger L, Krebs AR, Akalin A, Schübeler D. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation. Nature. 2015.
Baulier E, Diaz AGarcia, Corneo B, Farber DB. Generation of a human Ocular Albinism type 1 iPSC line, SEIi001-A, with a mutation in GPR143. Stem Cell Res. 2018;33:274-277.
Baumann H, Jahn M, Muenchau A, Trilck-Winkler M, Lohmann K, Seibler P. Generation and characterization of eight human-derived iPSC lines from affected and unaffected THAP1 mutation carriers. Stem Cell Res. 2018;33:60-64.
Baur K, Carrillo-García C, Şan Ş, von Hahn M, Strelau J, Hölzl-Wenig G, Mandl C, Ciccolini F. Growth/differentiation factor 15 controls ependymal and stem cell number in the V-SVZ. Stem Cell Reports. 2024.
Baur K, Şan Ş, Hölzl-Wenig G, Mandl C, Hellwig A, Ciccolini F. GDF15 controls primary cilia morphology and function thereby affecting progenitor proliferation. Life Sci Alliance. 2024;7(7).
Bautista F, Fioravantti V, Hernández C, de Prada I, López-Pino MÁngel, Ramírez M, Madero L, Moreno L. Glioblastoma, 47XXY/45,X mosaicism, and hyperpigmented skin lesions. Pediatr Blood Cancer. 2018:e27299.
Bawadud RS, Alkhatib MH. Growth and invasion inhibition of T47D ductal carcinoma cells by the association of docetaxel with a bioactive agent in neutral nanosuspension. Bioimpacts. 2023;13(2):145-157.
Bax M, Balez R, Muñoz SSanz, Do-Ha D, Stevens CH, Berg T, Cabral-da-Silva MC, Engel M, Nicholson G, Yang S, et al. Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF familial amyotrophic lateral sclerosis patient using mRNA reprogramming. Stem Cell Res. 2019;40:101530.
Bayarsaikhan D, Yoo DHoon, Lee J, Im YSam, Bayarsaikhan G, Kang H-A, Kim Y-O, Lee B. Generation and characterization of GATA6-specific EGFP expressing human induced pluripotent stem cell line, KSCBi017-A-1, using CRISPR/Cas9. Stem Cell Res. 2024;77:103426.
Bayin NS, Frenster JD, Kane JR, Rubenstein J, Modrek AS, Baitalmal R, Dolgalev I, Rudzenski K, Scarabottolo L, Crespi D, et al. GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth. Oncogenesis. 2016;5(10):e263.
Bayin NSumru, Modrek ASandaldjia, Placantonakis DGeorge. Glioblastoma stem cells: Molecular characteristics and therapeutic implications. World J Stem Cells. 2014;6(2):230-238.
Bchetnia M, Martineau L, Racine V, Powell J, McCuaig C, Morin C, Dupérée A, Gros-Louis F, Laprise C. Generation of two induced pluripotent stem cell lines (UQACi002-A and UQACi005-A) from two patients with KRT14 epidermolysis bullosa simplex mutations. Stem Cell Res. 2022;61:102750.
Bchetnia M, Martineau L, Racine V, Powell J, McCuaig C, Morin C, Dupérée A, Gros-Louis F, Laprise C. Generation of three induced pluripotent stem cell lines (UQACi003-A, UQACi004-A, and UQACi006-A) from three patients with KRT5 epidermolysis bullosa simplex mutations. Stem Cell Res. 2022;60:102726.
Begentas OCan, Koc D, Sendur NKayali, Besarat P, Ezgin S, Temel M, Bora HAyse Tokca, Kiris E. Generation and characterization of human induced pluripotent stem cell line METUi002-A from a patient with primary familial brain calcification (PFBC) carrying a heterozygous mutation (c.687dupT (p.Val230CysfsTer28)) in the SLC20A2 gene. Stem Cell Res. 2023;72:103226.
Bei JX, Zhang XL, Wu JK, Hu ZQ, Xu BL, Lin S, Cui L, Wu T, Zou LY. Ginsenoside Rb1 does not halt osteoporotic bone loss in ovariectomized rats. PLoS One. 2018;13(9):e0202885.
Bei HPan, Yang Y, Zhang Q, Tian Y, Luo X, Yang M, Zhao X. Graphene-Based Nanocomposites for Neural Tissue Engineering. Molecules. 2019;24(4).
Belbachir N, Lai C, Rhee J-W, Zhuge Y, Perez MV, Sallam K, Wu JC. Generation of two induced pluripotent stem cell lines from Brugada syndrome affected patients carrying SCN5A mutations. Stem Cell Res. 2021;57:102605.
Belk JA, Yao W, Ly N, Freitas KA, Chen Y-T, Shi Q, Valencia AM, Shifrut E, Kale N, Yost KE, et al. Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence. Cancer Cell. 2022.
Beltran AA, Molina SG, Marquez A, Munoz LJ, Olivares JF, Beltran AS. Generation of an induced pluripotent stem cell line (UNCCi002-A) from a healthy donor using a non-integration system to study Cerebral Cavernous Malformation (CCM). Stem Cell Res. 2021;54:102421.

Pages